• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA特征可预测冠状动脉搭桥术后的房颤。

MicroRNA signature predicts post operative atrial fibrillation after coronary artery bypass grafting.

作者信息

Yerukala Sathipati Srinivasulu, Carter Tonia, Soodi Deepa, Somto Nwaedozie, Shukla Sanjay K, Petronovich John, Ingrid Glurich, Braxton John, Sharma Param

机构信息

Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, 54449, USA.

Department of Cardiology, Marshfield Clinic Health System, Marshfield, WI, 54449, USA.

出版信息

Sci Rep. 2025 May 28;15(1):18658. doi: 10.1038/s41598-025-03042-3.

DOI:10.1038/s41598-025-03042-3
PMID:40436930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12119944/
Abstract

Early detection of atrial fibrillation (AFib) is crucial for altering its natural progression and complication profile. Traditional demographic and lifestyle factors often fail as predictors of AFib. This study investigated pre-operative, circulating microRNAs (miRNAs) as potential biomarkers for post-operative AFib (POAF) in patients undergoing coronary artery bypass grafting (CABG). We used an array polymerase chain reaction method to detect pre-operative, circulating miRNAs in seven patients who subsequently developed POAF after CABG (cases) and eight patients who did not develop POAF after CABG (controls). The top 10 miRNAs from 84 candidates were selected and assessed for their performance in predicting POAF using machine learning models, including Random Forest, K-Nearest Neighbors (KNN), XGBoost, and Support Vector Machine (SVM). The Random Forest and XGBoost models showed superior predictive performance, with test area under the curve (AUC) values of 0.76 and 0.83, respectively. Differential expression analysis revealed four upregulated miRNAs-hsa-miR-96-5p, hsa-miR-184, hsa-miR-17-3p, and hsa-miR-200-3p-that overlapped with the POAF-miRNA signature. The POAF-miRNA signature was significantly associated with various cardiovascular diseases, including acute myocardial infarction, hypertrophic cardiomyopathy, and heart failure. Biological pathway analysis indicated these miRNAs target key signaling pathways involved in cardiovascular pathology, such as the MAPK, PI3K-Akt, and TGF-beta signaling pathways. The identified miRNAs demonstrate significant potential as predictive biomarkers for AFib post-CABG, implicating critical cardiovascular pathways and highlighting their role in POAF development and progression. These findings suggest that miRNA signatures could enhance predictive accuracy for POAF, offering a novel, noninvasive approach to early detection and personalized management of this condition.

摘要

早期检测心房颤动(AFib)对于改变其自然病程和并发症情况至关重要。传统的人口统计学和生活方式因素往往无法作为AFib的预测指标。本研究调查了冠状动脉旁路移植术(CABG)患者术前循环微RNA(miRNA)作为术后心房颤动(POAF)潜在生物标志物的情况。我们采用阵列聚合酶链反应方法检测了7例CABG术后发生POAF的患者(病例组)和8例CABG术后未发生POAF的患者(对照组)术前的循环miRNA。从84个候选miRNA中选出排名前10的miRNA,并使用机器学习模型(包括随机森林、K近邻算法(KNN)、极端梯度提升(XGBoost)和支持向量机(SVM))评估它们预测POAF的性能。随机森林和XGBoost模型显示出卓越的预测性能,测试曲线下面积(AUC)值分别为0.76和0.83。差异表达分析揭示了4种上调的miRNA——hsa-miR-96-5p、hsa-miR-184、hsa-miR-17-3p和hsa-miR-200-3p——它们与POAF-miRNA特征重叠。POAF-miRNA特征与多种心血管疾病显著相关,包括急性心肌梗死、肥厚型心肌病和心力衰竭。生物学通路分析表明,这些miRNA靶向参与心血管病理过程的关键信号通路,如丝裂原活化蛋白激酶(MAPK)、磷脂酰肌醇-3激酶-蛋白激酶B(PI3K-Akt)和转化生长因子-β(TGF-β)信号通路。所鉴定的miRNA显示出作为CABG术后AFib预测生物标志物的巨大潜力,涉及关键的心血管通路,并突出了它们在POAF发生和发展中的作用。这些发现表明,miRNA特征可以提高POAF的预测准确性,为这种疾病的早期检测和个性化管理提供一种新的非侵入性方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/647c8665e285/41598_2025_3042_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/7c88beb3f604/41598_2025_3042_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/d28240b590ff/41598_2025_3042_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/45ee6bd01c22/41598_2025_3042_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/14b526a1c02d/41598_2025_3042_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/d16d0b3bdffe/41598_2025_3042_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/99b48b7e6794/41598_2025_3042_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/647c8665e285/41598_2025_3042_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/7c88beb3f604/41598_2025_3042_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/d28240b590ff/41598_2025_3042_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/45ee6bd01c22/41598_2025_3042_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/14b526a1c02d/41598_2025_3042_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/d16d0b3bdffe/41598_2025_3042_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/99b48b7e6794/41598_2025_3042_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c05/12119944/647c8665e285/41598_2025_3042_Fig7_HTML.jpg

相似文献

1
MicroRNA signature predicts post operative atrial fibrillation after coronary artery bypass grafting.微小RNA特征可预测冠状动脉搭桥术后的房颤。
Sci Rep. 2025 May 28;15(1):18658. doi: 10.1038/s41598-025-03042-3.
2
Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation.血清微小RNA 483-5p水平升高可能预示术后发生心房颤动风险的患者。
Eur J Cardiothorac Surg. 2017 Jan;51(1):73-78. doi: 10.1093/ejcts/ezw245. Epub 2016 Jul 15.
3
Predictors of post-operative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting.行单纯冠状动脉旁路移植术患者术后心房颤动的预测因素。
Kardiol Pol. 2018;76(1):195-201. doi: 10.5603/KP.a2017.0203. Epub 2017 Nov 23.
4
Analysis of Circulating miR-1, miR-23a, and miR-26a in Atrial Fibrillation Patients Undergoing Coronary Bypass Artery Grafting Surgery.接受冠状动脉搭桥手术的心房颤动患者循环中miR-1、miR-23a和miR-26a的分析
Ann Hum Genet. 2017 May;81(3):99-105. doi: 10.1111/ahg.12188.
5
Predictive Value of Age, Creatinine, and Ejection Fraction I and II Scores for Postoperative Atrial Fibrillation in Isolated On-Pump Coronary Artery Bypass Grafting Surgery: A Multicenter Retrospective Study.年龄、肌酐及射血分数 I 和 II 评分对非体外循环冠状动脉搭桥手术术后房颤的预测价值:一项多中心回顾性研究
Med Princ Pract. 2025;34(2):162-171. doi: 10.1159/000543188. Epub 2025 Jan 17.
6
Changed expression of microRNAs may predict postoperative atrial fibrillation in patients with cardiac surgery.微小 RNA 表达的改变可能预测心脏手术后患者的术后心房颤动。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):287-292. doi: 10.26355/eurrev_202101_24394.
7
Preoperative plasma biomarkers associated with atrial fibrillation after coronary artery bypass surgery.冠状动脉旁路手术后与心房颤动相关的术前血浆生物标志物。
J Thorac Cardiovasc Surg. 2021 Sep;162(3):851-863.e3. doi: 10.1016/j.jtcvs.2020.01.079. Epub 2020 Feb 19.
8
Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study.鉴定血浆 miR-4505、miR-4743-5p 和 miR-4750-3p 作为 2 型糖尿病患者冠心病的新型诊断生物标志物:病例对照研究。
Cardiovasc Diabetol. 2024 Jul 29;23(1):278. doi: 10.1186/s12933-024-02374-0.
9
Prediction of postoperative atrial fibrillation with left atrial mechanical functions and NT-pro ANP levels after coronary artery bypass surgery: A three-dimensional echocardiography study.冠状动脉搭桥术后左心房机械功能和N末端B型利钠肽原水平对术后心房颤动的预测:一项三维超声心动图研究
Echocardiography. 2018 May;35(5):661-666. doi: 10.1111/echo.13833. Epub 2018 Feb 19.
10
Pre-operative serum VCAM-1 as a biomarker of atrial fibrillation after coronary artery bypass grafting.术前血清血管细胞黏附分子-1作为冠状动脉搭桥术后房颤的生物标志物。
J Cardiothorac Surg. 2017 Aug 18;12(1):70. doi: 10.1186/s13019-017-0632-2.

本文引用的文献

1
KEGG: biological systems database as a model of the real world.京都基因与基因组百科全书(KEGG):作为现实世界模型的生物系统数据库。
Nucleic Acids Res. 2025 Jan 6;53(D1):D672-D677. doi: 10.1093/nar/gkae909.
2
Integrative experimental validation of concomitant miRNAs and transcription factors with differentially expressed genes in acute myocardial infarction.急性心肌梗死差异表达基因与同时存在的 miRNA 和转录因子的综合实验验证。
Eur J Pharmacol. 2024 May 15;971:176540. doi: 10.1016/j.ejphar.2024.176540. Epub 2024 Mar 27.
3
Lifestyle-Driven Variations in Nutrimiromic MicroRNA Expression Patterns across and beyond Genders.
跨性别及不同性别之外由生活方式驱动的营养基因组学微小RNA表达模式变化
Life (Basel). 2024 Mar 15;14(3):390. doi: 10.3390/life14030390.
4
Long noncoding RNA and messenger RNA profiling in epicardial adipose tissue of patients with new-onset postoperative atrial fibrillation after coronary artery bypass grafting.冠状动脉旁路移植术后新发术后心房颤动患者心外膜脂肪组织中的长非编码 RNA 和信使 RNA 谱分析。
Eur J Med Res. 2024 Feb 17;29(1):134. doi: 10.1186/s40001-024-01721-x.
5
An Integrated ddPCR Lab-on-a-Disc Device for Rapid Screening of Infectious Diseases.一种用于传染病快速筛查的集成式数字PCR芯片实验室设备。
Biosensors (Basel). 2023 Dec 21;14(1):2. doi: 10.3390/bios14010002.
6
HMDD v4.0: a database for experimentally supported human microRNA-disease associations.HMDD v4.0:一个实验支持的人类 microRNA-疾病关联数据库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1327-D1332. doi: 10.1093/nar/gkad717.
7
Role and regulatory mechanism of microRNA mediated neuroinflammation in neuronal system diseases.微小 RNA 介导的神经炎症在神经元系统疾病中的作用和调控机制。
Front Immunol. 2023 Aug 11;14:1238930. doi: 10.3389/fimmu.2023.1238930. eCollection 2023.
8
DIANA-miRPath v4.0: expanding target-based miRNA functional analysis in cell-type and tissue contexts.DIANA-miRPath v4.0:在细胞类型和组织背景下扩展基于靶标的 miRNA 功能分析。
Nucleic Acids Res. 2023 Jul 5;51(W1):W154-W159. doi: 10.1093/nar/gkad431.
9
MicroRNA Regulatory Network Analysis Using miRNet 2.0.基于 miRNet 2.0 的 microRNA 调控网络分析。
Methods Mol Biol. 2023;2594:185-204. doi: 10.1007/978-1-0716-2815-7_14.
10
Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis.通过加权基因共表达网络分析(WGCNA)和竞争性内源RNA(ceRNA)网络分析鉴定肥厚型心肌病的易感性模块和基因
Front Cell Dev Biol. 2022 Feb 1;9:822465. doi: 10.3389/fcell.2021.822465. eCollection 2021.